Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas
- PMID: 15696970
- DOI: 10.1007/BF02482184
Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas
Abstract
The matrix metalloproteinase (MMP) family members catalyze extracellular proteolysis. Recent reports have suggested that expression of MMP-2 and -9 might play a critical role in neoplastic tissue invasion or metastasis. In this study, the relationship between the expression of MMP-2 and -9 and the histological features of tissues from 21 cases of human glioma were investigated. MMP-2 and -9 proteins were detected by immnohistochemical studies. Amplification of MMP-2 and -9 mRNA was detected by reverse transcription-polymerase chain reaction (RT-PCR) assay. MMP-2 and -9 mRNA was measured quantitatively by the real-time RT-PCR method. Immunohistochemically, 38% of the cases were positive for MMP-2. Amplification of MMP-2 mRNA by RT-PCR was detected in 62% of the cases. There was no significant relationship between the expression of MMP-2 protein or mRNA and the biological nature of the tumors, including aggressiveness and histologic classification. The quantity of MMP-2 mRNA was 0.035 +/- 0.113 (MMP-2/GAPDH %), which was significantly elevated in cases of neoplastic dissemination or recurrence (P < 0.05). Tumor cells were immunohistochemically positive for MMP-9 in 81% of the samples. A positive reaction was found not only in neoplastic cells but also in endothelial cells, suggesting that the expression of MMP-9 protein might be associated with tumoral angiogenesis. The expression of mRNA in MMP-9 was detected in 91% of the cases, suggesting a close relationship between expression of MMP-9 and malignancy. The quantity of MMP-9 was 0.097 +/- 0.113 (MMP-9/GAPDH %) in all samples, which was significantly elevated in cases of glioblastoma (P < 0.05). The average Ki-67 labeling index was 8.14 +/- 5.26 in samples from G2 glioma, 19.92 +/- 11.29 in samples from G3 glioma, and 23.52 +/- 10.14 in samples from glioblastoma. All of the cases with elevated indices had recurrence or dissemination. The results of our study suggest that quantity analyses of MMP-2 and -9 mRNA and Ki-67 labeling index should be useful for discerning tumoral behaviors such as invasion, dissemination, and recurrence.
Similar articles
-
Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.Eur J Neurol. 2007 May;14(5):510-6. doi: 10.1111/j.1468-1331.2006.01705.x. Eur J Neurol. 2007. PMID: 17437609
-
Quantitative analysis of matrix metalloproteinase-2 mRNA expression in central and peripheral regions of gliomas.Brain Tumor Pathol. 2011 Apr;28(2):137-44. doi: 10.1007/s10014-011-0021-9. Epub 2011 Feb 18. Brain Tumor Pathol. 2011. PMID: 21331614
-
The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades.Brain Tumor Pathol. 2003;20(2):65-72. doi: 10.1007/BF02483449. Brain Tumor Pathol. 2003. PMID: 14756443
-
Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas.Neuro Oncol. 2000 Jul;2(3):145-50. doi: 10.1093/neuonc/2.3.145. Neuro Oncol. 2000. PMID: 11302334 Free PMC article.
-
The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.J Neurooncol. 2001 Jun;53(2):213-35. doi: 10.1023/a:1012280925031. J Neurooncol. 2001. PMID: 11716072 Review.
Cited by
-
Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China.J Neurooncol. 2007 Oct;85(1):65-73. doi: 10.1007/s11060-007-9392-5. Epub 2007 May 15. J Neurooncol. 2007. PMID: 17502998
-
Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands.J Drug Deliv. 2011;2011:160515. doi: 10.1155/2011/160515. Epub 2010 Dec 29. J Drug Deliv. 2011. PMID: 21490745 Free PMC article.
-
Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase-9 are prognostic markers in skull base chordomas.Neurosurg Rev. 2010 Apr;33(2):167-73; discussion 173. doi: 10.1007/s10143-009-0228-y. Epub 2009 Oct 28. Neurosurg Rev. 2010. PMID: 19862564
-
Matrix Metalloproteinases in Glioma: Drivers of Invasion and Therapeutic Targets.BioTech (Basel). 2025 Apr 15;14(2):28. doi: 10.3390/biotech14020028. BioTech (Basel). 2025. PMID: 40265458 Free PMC article. Review.
-
Does the functional polymorphism-1562C/T of MMP-9 gene influence brain disorders?Front Cell Neurosci. 2023 May 3;17:1110967. doi: 10.3389/fncel.2023.1110967. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37206663 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous